Showing results (181-190 of 214) with videos related to
Sort By:
Pageof 22
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution AnalysisJimmy J Caudell, Matthew C Ward, Nadeem Riaz, et al.Head & Neck|September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration studySara W Liu, Neil M Woody, Wei Wei, et al.International Journal of Radiation Oncology, Biology, Physics|September 4, 2017
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI CollaborativeMatthew C Ward, Nadeem Riaz, Jimmy J Caudell, et al.Cancers|January 26, 2024
Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer StageFilip Ionescu, Jonathan Nguyen, Carlos Moran Segura, et al.International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.Advances in Radiation Oncology|December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b StudyKamran A Ahmed, Youngchul Kim, John A Arrington, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.Journal of the National Cancer Institute|December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experienceLuana G Sousa, James Edward Bates, Payal Anand, et al.Oncotarget|October 21, 2016
Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinomaLu Chen, Courtney A Kurtyka, Eric A Welsh, et al.International Journal of Radiation Oncology, Biology, Physics|August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxxChristina L Runge, Jessica A Lyness, Maura L Gillison, et al.Pageof 22